PAVmed Inc

NASDAQ:PAVM   3:59:45 PM EDT
0.98
0.00 (-0.50%)
Earnings Announcements

Lucid Diagnostics Reports Q1 Preliminary Adjusted Loss Per Share Of $0.23

Published: 05/11/2022 20:09 GMT
PAVmed Inc (PAVM) - Q1 Preliminary Adjusted Non-GAAP Loss per Share $0.23.
Q1 GAAP Loss per Share $0.35.
Q1 Earnings per Share View $-0.30 -- Refinitiv Ibes Data (analyst estimates).
Lucid Had Cash and Cash Equivalents of $47.9 Million As of March 31, 2022.
Revenue is expected to be $0.36 Million
Adjusted EPS is expected to be -$0.23

Next Quarter Revenue Guidance is expected to be $1 Million
Next Quarter EPS Guidance is expected to be -$0.23

More details on our Analysts Page.